These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2641053)

  • 1. Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc.
    Jacobson AE
    NIDA Res Monogr; 1989; 95():556-77. PubMed ID: 2641053
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological evaluation of compounds for their physical dependence potential and abuse liability. XII. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1988).
    Jacobson A
    NIDA Res Monogr; 1988; 90():392-420. PubMed ID: 2908336
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological evaluation of compounds for their physical dependence potential and abuse liability. IX. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc. (1985).
    Jacobson AE
    NIDA Res Monogr; 1986; 67():385-98. PubMed ID: 3092095
    [No Abstract]   [Full Text] [Related]  

  • 4. Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).
    Aceto MD; Bowman ER; Harris LS; May EL
    NIDA Res Monogr; 1989; 95():578-631. PubMed ID: 2641054
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological evaluation of compounds for their physical dependence potential and abuse liability. VIII. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1984).
    Jacobson AE
    NIDA Res Monogr; 1984; 55():298-308. PubMed ID: 6152698
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological evaluation of compounds for their physical dependence potential and abuse liability. XVII. Drug Evaluation Committee of the College on Problems of Drug Dependence, Inc. (1993).
    Jacobson AE
    NIDA Res Monogr; 1994; 140():179-95. PubMed ID: 8722465
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological evaluation of compounds for their dependence liability. VII. Drug Testing Program of the Committee on Problems of Drug dependence, Inc. (1983).
    Jacobson AE
    NIDA Res Monogr; 1984 Mar; 49():352-60. PubMed ID: 6148694
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological evaluation of compounds for their dependence liability. VI. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1982).
    Jacobson AE
    NIDA Res Monogr; 1983 Apr; 43():389-98. PubMed ID: 6410274
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological evaluation of compounds for their physical dependence potential and abuse liability. XVI. Drug Evaluation Committee of the College of Problems of Drug Dependence, Inc. (1992).
    Jacobson AE
    NIDA Res Monogr; 1993; 132():437-58. PubMed ID: 8101975
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological evaluation of compounds for their dependence liability. V. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1981).
    Jacobson AE
    NIDA Res Monogr; 1982 Apr; 41():331-7. PubMed ID: 6811928
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological evaluation of compounds for their physical dependence potential and abuse liability. XI. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1987).
    Jacobson A
    NIDA Res Monogr; 1988; 81():466-84. PubMed ID: 2900468
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological evaluation of compounds for their physical dependence potential and abuse liability. XXI. Drug evaluation committee of the college on problems of drug dependence (1997).
    Jacobson AE
    NIDA Res Monogr; 1998 Mar; 178():346-62. PubMed ID: 9686403
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological evaluation of compounds for their physical dependence potential and abuse liability. XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1990).
    Jacobson AE
    NIDA Res Monogr; 1990; 105():622-39. PubMed ID: 1876149
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological evaluation of compounds for their physical dependence potential and abuse liability, XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1991).
    Jacobson AE
    NIDA Res Monogr; 1992; 119():490-512. PubMed ID: 1435983
    [No Abstract]   [Full Text] [Related]  

  • 15. Annual report: biological evaluation of compounds for their dependence liability. IV. Drug testing program of the Committee on Problems of Drug, Dependence, Inc. (1980).
    Jacobson AE
    NIDA Res Monogr; 1981 Feb; 34():287-96. PubMed ID: 6783943
    [No Abstract]   [Full Text] [Related]  

  • 16. Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc.
    NIDA Res Monogr; 1984; 52():1-153. PubMed ID: 6148699
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986).
    Jacobson AE
    NIDA Res Monogr; 1987; 76():370-91. PubMed ID: 2893982
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of new compounds for opioid activity: 1986 annual report.
    Woods JH; Smith CB; Medzihradsky F; Winger GD; Gmerek DE
    NIDA Res Monogr; 1987; 76():448-84. PubMed ID: 3125469
    [No Abstract]   [Full Text] [Related]  

  • 20. Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendations.
    Br J Addict; 1991 Dec; 86(12):1527-8. PubMed ID: 1786481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.